Results 121 to 130 of about 19,854 (197)

LDL receptor-independent mechanisms of proprotein convertase subtilisin/kexin type 9 in cardiovascular pathophysiology. [PDF]

Front Cardiovasc Med
Su H, Guo X, Li Q, Yuan X, Wu X, Zhao Z, Kan Y, Yang Y, Fu Z, Qi Z, Song G.   +10 more
europepmc   +1 more source

Advancing Lipid Management: Saudi Heart Association Position Statement on PCSK9-targeted Therapies in the Primary and Secondary Prevention of Cardiovascular Disease. [PDF]

J Saudi Heart Assoc
AlHabeeb W, Alamri H, Elbadawi H, AlRuthia YS, Alharbi W, Alshammeri O, Tash A, Almoziny S, Kholaif N, Halawani H, AlMahdi F, Yar W, Alhabib KF.   +12 more
europepmc   +1 more source

PCSK9 Inhibitors

Journal of the American College of Cardiology, 2017
Mark A. Hlatky, Dhruv S. Kazi
openaire   +2 more sources

Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis. [PDF]

Medicine (Baltimore)
Du W, Li D, Li N, Zhang W, Wang J, Wang T, Zeng Y.   +6 more
europepmc   +1 more source

RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. [PDF]

Research (Wash D C)
Ali I, Qiu J, Cheang WS, Wang G, Xu S.
europepmc   +1 more source

PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosis. [PDF]

Atheroscler Plus
Amorosi A, Varret M.
europepmc   +1 more source

High-efficacy serum biomarkers PCSK9 and LCAT predict cognitive impairment in Parkinson's disease. [PDF]

Front Psychol
Su M, Yang T, Fan X, Qiang X, Liao Z, Gu H, Gao L, Chen R, Tang C, Mu C.   +9 more
europepmc   +1 more source

Pharmacogenomics of Atherosclerotic Plaque: Pathophysiological Background and Therapeutic Perspectives. [PDF]

Curr Atheroscler Rep
Mauriello A, De Falco A, Correra A, D'Andrea A, Giallauria F, Giordano A, Russo V.   +6 more
europepmc   +1 more source

Role of Hyperlipidemia-Related <i>PCSK9</i>, <i>APOE</i>, and <i>LRP8</i> Variants in Restenosis after Stent Implantation in Male Patients: A Case-Control Study. [PDF]

Mol Syndromol
Ozkara G, Aslan EI, Ser OS, Kilicarslan O, Kucukhuseyin O, Bostan C, Yildiz A, Ozturk O, Yilmaz-Aydogan H.   +8 more
europepmc   +1 more source

PCSK9 Inhibition

JACC: Basic to Translational Science, 2023
openaire   +1 more source